Detalles de la búsqueda
1.
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
Int J Gynecol Cancer
; 30(7): 1065-1070, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32447296
2.
Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use.
J Transl Med
; 17(1): 82, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871636
3.
A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer.
J Transl Med
; 16(1): 196, 2018 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012146
4.
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
Clin Cancer Res
; 29(2): 349-363, 2023 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36099324
5.
Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Gynecol Oncol Rep
; 30: 100506, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31867430
6.
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
Clin Cancer Res
; 29(2): 501, 2023 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36647676
7.
Proteasome inhibitors: structure and function.
Semin Oncol
; 44(6): 377-380, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29935898
8.
Monocyte and interferon based therapy for the treatment of ovarian cancer.
Cytokine Growth Factor Rev
; 29: 109-15, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27026228
Resultados
1 -
8
de 8
1
Próxima >
>>